These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 12626998)

  • 1. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation with prostacyclin and heparin during continuous venovenous hemofiltration.
    Langenecker SA; Felfernig M; Werba A; Mueller CM; Chiari A; Zimpfer M
    Crit Care Med; 1994 Nov; 22(11):1774-81. PubMed ID: 7956281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor.
    Xiao Z; Théroux P; Frojmovic M
    Thromb Haemost; 1999 Feb; 81(2):281-5. PubMed ID: 10064007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
    Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M
    Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iloprost for additional anticoagulation in continuous renal replacement therapy--a pilot study.
    Birnbaum J; Spies CD; Klotz E; Hein OV; Morgera S; Schink T; Ziemer S; Grund MS; Saalmann R; Kox WJ; Lehmann C
    Ren Fail; 2007; 29(3):271-7. PubMed ID: 17497439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of uniform platelet activation in patients after ischemic stroke and choice of antiplatelet therapy.
    Serebruany VL; Malinin AI; Oshrine BR; Sane DC; Takserman A; Atar D; Hennekens CH
    Thromb Res; 2004; 113(3-4):197-204. PubMed ID: 15140583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
    Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
    Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation after stenting with heparin-coated versus noncoated stents.
    Gurbel PA; Bliden KP
    Am Heart J; 2003 Oct; 146(4):E10. PubMed ID: 14564333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
    Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
    Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study.
    Fabbri LP; Nucera M; Al Malyan M; Becchi C
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):92-7. PubMed ID: 19650808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
    Serebruany VL; Malinin AI; O'connor CM; Gurbel PA;
    Am Heart J; 2003 Jul; 146(1):91-8. PubMed ID: 12851613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.
    Haas S; Walenga JM; Jeske WP; Fareed J
    Semin Thromb Hemost; 1999; 25 Suppl 1():67-75. PubMed ID: 10357155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent.
    Fiaccadori E; Maggiore U; Rotelli C; Minari M; Melfa L; Cappè G; Cabassi A
    Intensive Care Med; 2002 May; 28(5):586-93. PubMed ID: 12029407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting.
    Antonino MJ; Mahla E; Bliden KP; Tantry US; Gurbel PA
    Am J Cardiol; 2009 Jun; 103(11):1546-50. PubMed ID: 19463513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effects of Escherichia coli capsular-derived sulfaminoheparosans and heparins on tissue factor-mediated activation of platelets: flow cytometric analysis.
    Maddineni J; Jeske WP; Baltasar F; Cornelli U; Manoni M; Hoppensteadt DA; Fareed J
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):311-7. PubMed ID: 16959684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S; Della Pina F; Rizza A; Buffa M; De Filippis R; Gianetti J; Clerico A
    Cytometry B Clin Cytom; 2008 Jan; 74(1):30-9. PubMed ID: 17630652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of platelet reactivity by enoxaparin compared with unfractionated heparin in patients undergoing haemodialysis.
    Aggarwal A; Whitaker DA; Rimmer JM; Solomon RJ; Gennari FJ; Sobel BE; Schneider DJ
    Nephrol Dial Transplant; 2004 Jun; 19(6):1559-63. PubMed ID: 15034156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.